- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/537 - ImmunoassayBiospecific binding assayMaterials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
Patent holdings for IPC class G01N 33/537
Total number of patents in this class: 294
10-year publication summary
|
22
|
15
|
19
|
26
|
16
|
34
|
18
|
20
|
5
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20153 |
13 |
| President and Fellows of Harvard College | 6009 |
9 |
| Genzyme Corporation | 1295 |
6 |
| MedImmune Limited | 622 |
5 |
| Terumo Kabushiki Kaisha | 5621 |
4 |
| National Jewish Health | 168 |
4 |
| Prometheus Laboratories Inc. | 95 |
4 |
| Swiss Analyze Bacteria AG | 4 |
4 |
| FUJIFILM Corporation | 29713 |
3 |
| The General Hospital Corporation | 4787 |
3 |
| Cytosed, Inc. | 3 |
3 |
| Spring Bioscience Corporation | 18 |
3 |
| BT BIDCO, Inc. | 81 |
3 |
| Novartis AG | 10707 |
2 |
| F. Hoffmann-La Roche AG | 7946 |
2 |
| Roche Diagnostics Operations, Inc. | 1501 |
2 |
| Nestec S.A. | 2642 |
2 |
| International Business Machines Corporation | 61616 |
2 |
| Robert Bosch GmbH | 42861 |
2 |
| Glaxosmithkline Biologicals S.A. | 1651 |
2 |
| Other owners | 216 |